SA’s medicines regulator has suspended two members of its inspectorate and is facing a probe from the Special Investigating Unit (SIU) for alleged fraud relating to an undisclosed "external stakeholder".

The probe raises questions about the processes for seeking regulatory approval for medicines and manufacturing sites and whether they have been tampered with, as well as the integrity of the products on the market. But the SA Health Products Regulatory Agency (Sahpra) assured consumers on Monday that the investigation will not affect the health and safety of the public "in any way".

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now